These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
202 related items for PubMed ID: 7868269
1. Differential activation of Brucella-reactive CD4+ T cells by Brucella infection or immunization with antigenic extracts. Zhan Y, Kelso A, Cheers C. Infect Immun; 1995 Mar; 63(3):969-75. PubMed ID: 7868269 [Abstract] [Full Text] [Related]
2. Cytokine production in the murine response to brucella infection or immunization with antigenic extracts. Zhan Y, Kelso A, Cheers C. Immunology; 1993 Nov; 80(3):458-64. PubMed ID: 8288319 [Abstract] [Full Text] [Related]
3. Protection of BALB/c mice against Brucella abortus 544 challenge by vaccination with bacterioferritin or P39 recombinant proteins with CpG oligodeoxynucleotides as adjuvant. Al-Mariri A, Tibor A, Mertens P, De Bolle X, Michel P, Godefroid J, Walravens K, Letesson JJ. Infect Immun; 2001 Aug; 69(8):4816-22. PubMed ID: 11447155 [Abstract] [Full Text] [Related]
4. Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infection. Pasquevich KA, Estein SM, García Samartino C, Zwerdling A, Coria LM, Barrionuevo P, Fossati CA, Giambartolomei GH, Cassataro J. Infect Immun; 2009 Jan; 77(1):436-45. PubMed ID: 18981242 [Abstract] [Full Text] [Related]
5. Cytokine response of T-cell subsets from Brucella abortus-infected mice to soluble Brucella proteins. Zhan Y, Yang J, Cheers C. Infect Immun; 1993 Jul; 61(7):2841-7. PubMed ID: 8514387 [Abstract] [Full Text] [Related]
6. Recombinant outer membrane protein 25c from Brucella abortus induces Th1 and Th2 mediated protection against Brucella abortus infection in mouse model. Paul S, Peddayelachagiri BV, Nagaraj S, Kingston JJ, Batra HV. Mol Immunol; 2018 Jul; 99():9-18. PubMed ID: 29649688 [Abstract] [Full Text] [Related]
7. Protective and therapeutic efficacy study of divalent fusion protein rL7/L12-Omp25 against B. abortus 544 in presence of IFNγ. Paul S, Peddayelachagiri BV, Nagaraj S, Konduru B, Batra HV. Appl Microbiol Biotechnol; 2018 Oct; 102(20):8895-8907. PubMed ID: 30136204 [Abstract] [Full Text] [Related]
8. Vaccination with the recombinant Brucella outer membrane protein 31 or a derived 27-amino-acid synthetic peptide elicits a CD4+ T helper 1 response that protects against Brucella melitensis infection. Cassataro J, Estein SM, Pasquevich KA, Velikovsky CA, de la Barrera S, Bowden R, Fossati CA, Giambartolomei GH. Infect Immun; 2005 Dec; 73(12):8079-88. PubMed ID: 16299302 [Abstract] [Full Text] [Related]
9. Intraspleen delivery of a DNA vaccine coding for superoxide dismutase (SOD) of Brucella abortus induces SOD-specific CD4+ and CD8+ T cells. Muñoz-Montesino C, Andrews E, Rivers R, González-Smith A, Moraga-Cid G, Folch H, Céspedes S, Oñate AA. Infect Immun; 2004 Apr; 72(4):2081-7. PubMed ID: 15039330 [Abstract] [Full Text] [Related]
10. Immunization with Brucella VirB proteins reduces organ colonization in mice through a Th1-type immune response and elicits a similar immune response in dogs. Pollak CN, Wanke MM, Estein SM, Delpino MV, Monachesi NE, Comercio EA, Fossati CA, Baldi PC. Clin Vaccine Immunol; 2015 Mar; 22(3):274-81. PubMed ID: 25540276 [Abstract] [Full Text] [Related]
11. A Brucella melitensis M5-90 wboA deletion strain is attenuated and enhances vaccine efficacy. Li ZQ, Shi JX, Fu WD, Zhang Y, Zhang J, Wang Z, Li TS, Chen CF, Guo F, Zhang H. Mol Immunol; 2015 Aug; 66(2):276-83. PubMed ID: 25899866 [Abstract] [Full Text] [Related]
12. Tumor necrosis factor alpha and interleukin-12 contribute to resistance to the intracellular bacterium Brucella abortus by different mechanisms. Zhan Y, Liu Z, Cheers C. Infect Immun; 1996 Jul; 64(7):2782-6. PubMed ID: 8698508 [Abstract] [Full Text] [Related]
13. Escheriosomes entrapped DNA vaccine co-expressing Cu-Zn superoxide dismutase and IL-18 confers protection against Brucella abortus. Singha H, Mallick AI, Jana C, Isore DP, Goswami TK, Srivastava SK, Azevedo VA, Chaudhuri P, Owais M. Microbes Infect; 2008 Jul; 10(10-11):1089-96. PubMed ID: 18602490 [Abstract] [Full Text] [Related]
14. Vaccination with Brucella recombinant DnaK and SurA proteins induces protection against Brucella abortus infection in BALB/c mice. Delpino MV, Estein SM, Fossati CA, Baldi PC, Cassataro J. Vaccine; 2007 Sep 17; 25(37-38):6721-9. PubMed ID: 17686554 [Abstract] [Full Text] [Related]
15. Attenuated Salmonella secreting Brucella protective antigens confer dual-faceted protection against brucellosis and salmonellosis in a mouse model. Senevirathne A, Hewawaduge C, Lee JH. Vet Immunol Immunopathol; 2019 Mar 17; 209():31-36. PubMed ID: 30885303 [Abstract] [Full Text] [Related]
16. Humoral immunity and CD4+ Th1 cells are both necessary for a fully protective immune response upon secondary infection with Brucella melitensis. Vitry MA, Hanot Mambres D, De Trez C, Akira S, Ryffel B, Letesson JJ, Muraille E. J Immunol; 2014 Apr 15; 192(8):3740-52. PubMed ID: 24646742 [Abstract] [Full Text] [Related]
17. Evaluation of Th1/Th2-Related Immune Response against Recombinant Proteins of Brucella abortus Infection in Mice. Im YB, Park WB, Jung M, Kim S, Yoo HS. J Microbiol Biotechnol; 2016 Jun 28; 26(6):1132-9. PubMed ID: 27012238 [Abstract] [Full Text] [Related]
18. Immunization of BALB/c mice with a combination of four recombinant Brucella abortus proteins, AspC, Dps, InpB and Ndk, confers a marked protection against a virulent strain of Brucella abortus. Hop HT, Arayan LT, Huy TXN, Reyes AWB, Min W, Lee HJ, Park SJ, Chang HH, Kim S. Vaccine; 2018 May 17; 36(21):3027-3033. PubMed ID: 29678458 [Abstract] [Full Text] [Related]
19. Recombinant Brucella abortus proteins that induce proliferation and gamma-interferon secretion by CD4+ T cells from Brucella-vaccinated mice and delayed-type hypersensitivity in sensitized guinea pigs. Oliveira SC, Harms JS, Banai M, Splitter GA. Cell Immunol; 1996 Sep 15; 172(2):262-8. PubMed ID: 8964089 [Abstract] [Full Text] [Related]
20. Improved immunogenicity and protective efficacy of a divalent DNA vaccine encoding Brucella L7/L12-truncated Omp31 fusion protein by a DNA priming and protein boosting regimen. Golshani M, Rafati S, Siadat SD, Nejati-Moheimani M, Shahcheraghi F, Arsang A, Bouzari S. Mol Immunol; 2015 Aug 15; 66(2):384-91. PubMed ID: 25968974 [Abstract] [Full Text] [Related] Page: [Next] [New Search]